Uncoordinated price cuts across the EU are contributing to medicine shortages and driving manufacturers towards more ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

GSK Plc shares tumbled after its blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

Despite not meeting the endpoint, subjects have experienced a meaningful improvement in RBC transfusion independence.

Following the FDA ODD, European designation underscores ICT01’s potential as a ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production ...

Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.

Despite a phase 3 flop, Bristol Myers Squibb—encouraged by “clinically meaningful results” and bruised by three other recent ...

Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...

In today's fast-paced world of artificial intelligence and enterprise technology, few leaders embody both technical depth and ...